Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is the third leading cause of cancer-related death in the world. Major risk factors for liver cancer include...
The HCC Biomarker tests AFP-L3 and DCP are in vitro diagnostic blood tests for the risk assessment of developing Hepatocellular Carcinoma (HCC). Both tests are used in conjunction with...
µTASWako™ AFP-L3 Test is an in vitro diagnostic blood test for the risk assessment of developing Hepatocellular Carcinoma (HCC).
AFP-L3 is an isoform of the glycoprotein alpha-...
µTASWako™ DCP Test is an in vitro diagnostic blood test for the risk assessment of developing Hepatocellular Carcinoma (HCC).
DCP (des-gamma-carboxy prothrombin) is an immature...
µTASWako™ i30 (Micro Total Analysis System) is the worldwide unique system for the automated measurement of the biomarkers AFP-L3 and DCP.
Both, AFP-L3 (lectin-reactive alpha-...
FUJIFILM Wako Chemicals Europe GmbH
41468 Neuss, Germany
I acknowledge that I can revoke this consent at any time and my revocation has legal effect only for the future after the revocation.